Viewing nowCombinationEmpaAnduo Tablets 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dong-A Bio Pharmaceutical Co., Ltd.

MFDS item code 202201299 · Approved 2022.04.04 · Insurance code 657309090
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood glucose levels in adult patients with type 2 diabetes. It is particularly suitable for patients whose blood glucose levels are not adequately controlled, and patients with cardiovascular diseases should consult the manufacturer's precautions. Overall, it is effective in improving blood glucose control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant treatment with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated using the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, subsection 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, subsection 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This medication is used for the treatment of diabetes, and the two ingredients work together to control blood glucose levels. There is a risk of rare side effects such as severe lactic acidosis when using this medication, so caution is needed. Lactic acidosis is a dangerous condition caused by excessive accumulation of lactic acid in the body, and symptoms may include difficulty breathing, abdominal pain, and lethargy. Additionally, when taken with other diabetes medications like insulin or sulfonylureas, hypoglycemia may occur, so blood glucose levels should be carefully monitored. Patients with poor kidney function or acute kidney issues, severe infections, heart failure, or acute myocardial infarction should not take this medication. Patients who are scheduled for surgery or tests involving iodine contrast agents should stop taking this medication for a certain period and may resume only after kidney function has returned to normal. This medication may cause fluid volume loss, so extra caution is needed when experiencing symptoms of dehydration, diarrhea, or vomiting. It is advisable for pregnant or breastfeeding women to avoid this medication, and elderly patients may require regular check-ups due to the possibility of declining kidney function. During treatment, urinary or genital infections may occur, so patients should consult a doctor immediately if symptoms arise. Vitamin B12 levels may decrease, so regular blood tests are recommended for long-term use. Alcohol consumption may increase the risk of side effects of this medication and should be avoided. If symptoms of hypoglycemia (such as dizziness, cold sweat, fatigue) occur while taking this medication, blood glucose should be checked immediately and appropriate measures should be taken if necessary. Lastly, this medication is not recommended for children, and in cases of overdose, immediate medical attention should be sought. To use this medication safely, regular kidney function tests and blood glucose monitoring are important, and it should be taken as directed by a doctor.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.
Yellowish-white, biconvex, oval film-coated tablet
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dong-A Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.